Article Sidebar
Views pdf: 0
CLINICAL AND PARACLINICAL CHARACTERISTICS OF PAPILLARY THYROID CARCINOMA PATIENTS TREATED WITH TRANSORAL ENDOSCOPIC THYROID-CONSERVING SURGERY AT HANOI MEDICAL UNIVERSITY HOSPITAL
Main Article Content
Abstract
Objectives: To describe the clinical and paraclinical characteristics of patients with early-stage papillary thyroid carcinoma treated by transoral endoscopic thyroidectomy vestibular approach (TOETVA). Methods: A cross-sectional descriptive study was conducted on 144 patients diagnosed with early-stage papillary thyroid carcinoma (cT1N0M0) who underwent TOETVA at the Oncology Center, Hanoi Medical University Hospital, between March 2023 and March 2024. Data collected included demographic information, ultrasound features (size, TIRADS classification, location), operative parameters (time, blood loss, hospital stay), and lymph node dissection outcomes. Results: The average age was 36.4 ± 7.6 years; 95.1% were female. Most patients had solitary nodules (>5 mm) with average was 6,1 ± 2,0mm, classified as TIRADS 4 or 5, commonly located in the mid-third of the thyroid lobe. Mean operative time was 71.2 ± 16.2 minutes; average blood loss was 7.8 ± 4.7 ml; and average hospital stay was 3.4 ± 1.3 days. Central lymph node metastasis was detected in 26.4% of patients, with a median of 5 nodes harvested and 1 metastatic node per case with nodal involvement. Hoarseness and paresthesia were observed in 4.9% and 2.8% of patients, respectively. Conclusions: TOETVA is a safe and effective surgical option for patients with early-stage papillary thyroid carcinoma. It offers favorable outcomes in terms of operative safety, recovery time, and cosmetic results
Article Details
Keywords
Papillary thyroid carcinoma, TOETVA, endoscopic thyroidectomy, central lymph node dissection, minimally invasive surgery
References
2. Papini E, Guglielmi R, Novizio R, Pontecorvi A, Durante C. Management of low-risk papillary thyroid cancer. Minimally-invasive treatments dictate a further paradigm shift? Endocrine. 2024 Aug 1;85(2):584–92.
3. Anuwong A, Sasanakietkul T, Jitpratoom P, Ketwong K, Kim HY, Dionigi G, et al. Transoral endoscopic thyroidectomy vestibular approach (TOETVA): indications, techniques and results. Surg Endosc. 2018 Jan;32(1):456–65.
4. Nguyen HX, Hien Nguyen Xuan, Hoai Thi Hoang, Quang Le Van LV. Quality of Life and Surgical Outcome of Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) versus Open Thyroid Surgery: Experience from a Single Center in Vietnam. Journal of Thyroid Research.
5. Anuwong A. Transoral Endoscopic Thyroidectomy Vestibular Approach: A Series of the First 60 Human Cases. World J Surg. 2016 Mar;40(3):491–7.
6. Dionigi G, Bacuzzi A, Lavazza M, Inversini D, Boni L, Rausei S, et al. Transoral endoscopic thyroidectomy: preliminary experience in Italy. Updates Surg. 2017 Jun;69(2):225–34.
7. Zhang W, Jiang D zhen, Liu S, Li L jie, Zheng X min, Shen H liang, et al. Current status of endoscopic thyroid surgery in China. Surg Laparosc Endosc Percutan Tech. 2011 Apr;21(2):67–71.
8. Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017 Jun 27;8(37):62414–24.
9. Arikan M, Riss P, Scheuba C, Schopf S, Karakas E, Klein G, et al. Transoral Thyroidectomy: Initial Results of the European TOETVA Study Group. World J Surg. 2023 May 1;47(5):1201–8.
10. Deroide G, Honigman I, Berthe A, Branger F, Cussac-Pillegand C, Richa H, et al. Trans oral endoscopic thyroidectomy (TOETVA): First French experience in 90 patients. Journal of Visceral Surgery. 2021 Apr 1;158(2):103–10.